Resistance mechanisms in Campylobacter jejuni

Virulence

Volumn 4, Issue 3, 2013, Pages 230-240

  Iovine, Nicole M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Antibiotic resistance; Campylobacter jejuni; CmeABC; Efflux pump; Major outer membrane protein; MOMP; Porin

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; ERYTHROMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; CAMPYLOBACTER; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; DIARRHEA; GASTROENTERITIS; GENE DOSAGE; GENE INSERTION SEQUENCE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MORTALITY; NONHUMAN; POINT MUTATION; PROTEIN SYNTHESIS INHIBITION; REVIEW;

EID: 84875963871     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.23753     Document Type: Review

References (161)

1. Zilbauer M, Dorrell N, Wren BW, Bajaj-Elliott M. Campylobacter jejuni-mediated disease pathogenesis: an update. Trans R Soc Trop Med Hyg 2008; 102:123-9; PMID:18023831; http://dx.doi.org/10.1016/j. trstmh.2007.09.019
2. Eurosurveillance editorial team. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2010. Euro Surveill 2012; 17:20113; PMID:22433599.
3. EFSA. The Community Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from animals and food in the European Union in 2008. Eur Food Safety Auth J 2010; 8:1658-919.
4. OzFoodNet Working Group. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet Network, 2009. Commun Dis Intell 2010; 34:396-426; PMID:21413526.
5. Notifiable and Other Diseases in New Zealand. Annula Report 2011. In: The Institute of Environmental Science and Research Ltd. Porirua, New Zealand; 2012.
6. Allos BM, Blaser MJ. Campylobacter jejuni and related species. In: Mandell, ed. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2010:2793-802.
7. Blaser MJ, Taylor DN, Feldman RA. Epidemiology of Campylobacter jejuni infections. Epidemiol Rev 1983; 5:157-76; PMID:6357819.
8. Centers for Disease Control and Prevention (CDC). Incidence of foodborne illnesses: preliminary data from the Foodborne Diseases Active Surveillance Network (FoodNet)--United States, 1998. MMWR Morb Mortal Wkly Rep 1999; 48:189-94; PMID:10208124.
9. FoodNet-Foodborne Diseases Active Surveillance Network. Centers for Disease Control and Prevention, 2012. (Accessed March 14, 2012, at http://www.cdc. gov/foodnet/.)
10. Thomas C, Gibson H, Hill DJ, Mabey M. Campylobacter epidemiology: an aquatic perspective. J Appl Microbiol 1998; 85(Suppl 1):168S-77S; PMID:21182706; http://dx.doi. org/10.1111/j.1365-2672.1998.tb05296.x
11. Endtz HP, Ruijs GJ, van Klingeren B, Jansen WH, van der Reyden T, Mouton RP. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother 1991; 27:199-208; PMID:2055811; http://dx.doi.org/10.1093/ jac/27.2.199
12. Gupta A, Nelson JM, Barrett TJ, Tauxe RV, Rossiter SP, Friedman CR, et al.; NARMS Working Group. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg Infect Dis 2004; 10:1102-9; PMID:15207064; http://dx.doi. org/10.3201/eid1006.030635
13. Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol 2009; 4:189-200; PMID:19257846; http:// dx.doi.org/10.2217/17460913.4.2.189
14. Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, et al.; Investigation Team. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999; 340:1525-32; PMID:10332013; http://dx.doi. org/10.1056/NEJM199905203402001
15. Threlfall EJ, Ward LR, Frost JA, Willshaw GA. Spread of resistance from food animals to man--the UK experience. Acta Vet Scand Suppl 2000; 93:63-8, discussion 68-74; PMID:10822859.
16. van Boven M, Veldman KT, de Jong MC, Mevius DJ. Rapid selection of quinolone resistance in Campylobacter jejuni but not in Escherichia coli in individually housed broilers. J Antimicrob Chemother 2003; 52:719-23; PMID:12951353; http://dx.doi. org/10.1093/jac/dkg402
17. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001; 7:337-41; PMID:11294736; http://dx.doi.org/10.3201/ eid0702.010239
18. Moore JE, Barton MD, Blair IS, Corcoran D, Dooley JS, Fanning S, et al. The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect 2006; 8:1955-66; PMID:16716632; http://dx.doi. org/10.1016/j.micinf.2005.12.030
19. Kittl S, Kuhnert P, Hächler H, Korczak BM. Comparison of genotypes and antibiotic resistance of Campylobacter jejuni isolated from humans and slaughtered chickens in Switzerland. J Appl Microbiol 2011; 110:513-20; PMID:21143711; http://dx.doi. org/10.1111/j.1365-2672.2010.04906.x
20. Monitoring antimicrobial usage in food animals for the protection of human health: Report of a WHO consultation. World Health Organization Department of Communicable Disease, Surveillance and Response 2001.
21. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al.; Infectious Diseases Society of America. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32:331-51; PMID:11170940; http://dx.doi.org/10.1086/318514
22. Sarmah AK, Meyer MT, Boxall AB. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere 2006; 65:725-59; PMID:16677683; http://dx.doi.org/10.1016/j.chemosphere. 2006.03.026
23. Council regulation (EC) No. 2821/98 of 17 December 1998 amending, as regards withdrawal of the authorization of certain antibiotics, Directive 70/524/EEC concerning additives in feedingstuffs. Official Journal of the European Communities 1998; 351:4-8.
24. Ansary A, Radu S. Conjugal transfer of antibiotic resistances and plasmids from Campylobacter jejuni clinical isolates. FEMS Microbiol Lett 1992; 70:125-8; PMID:1587459; http://dx.doi. org/10.1111/j.1574-6968.1992.tb05196.x
25. Bradbury WC, Munroe DL. Occurrence of plasmids and antibiotic resistance among Campylobacter jejuni and Campylobacter coli isolated from healthy and diarrheic animals. J Clin Microbiol 1985; 22:339-46; PMID:4044793.
26. Gibreel A, Sköld O. High-level resistance to trimethoprim in clinical isolates of Campylobacter jejuni by acquisition of foreign genes (dfr1 and dfr9) expressing drug-insensitive dihydrofolate reductases. Antimicrob Agents Chemother 1998; 42:3059-64; PMID:9835491.
27. Gibreel A, Sköld O, Taylor DE. Characterization of plasmid-mediated aphA-3 kanamycin resistance in Campylobacter jejuni. Microb Drug Resist 2004; 10:98-105; PMID:15256024; http://dx.doi. org/10.1089/1076629041310127
28. Gibreel A, Tracz DM, Nonaka L, Ngo TM, Connell SR, Taylor DE. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance. Antimicrob Agents Chemother 2004; 48:3442-50; PMID:15328109; http://dx.doi.org/10.1128/AAC.48.9.3442-3450.2004
29. Lambert T, Gerbaud G, Trieu-Cuot P, Courvalin P. Structural relationship between the genes encoding 3'-aminoglycoside phosphotransferases in Campylobacter and in gram-positive cocci. Ann Inst Pasteur Microbiol 1985; 136B:135-50; PMID:3002237; http://dx.doi.org/10.1016/S0769-2609(85)80040-5
30. Lee MD, Sanchez S, Zimmer M, Idris U, Berrang ME, McDermott PF. Class 1 integron-associated tobramycin-gentamicin resistance in Campylobacter jejuni isolated from the broiler chicken house environment. Antimicrob Agents Chemother 2002; 46:3660-4; PMID:12384387; http://dx.doi.org/10.1128/ AAC.46.11.3660-3664.2002
31. Nirdnoy W, Mason CJ, Guerry P. Mosaic structure of a multiple-drug-resistant, conjugative plasmid from Campylobacter jejuni. Antimicrob Agents Chemother 2005; 49:2454-9; PMID:15917546; http://dx.doi. org/10.1128/AAC.49.6.2454-2459.2005
32. O'Halloran F, Lucey B, Cryan B, Buckley T, Fanning S. Molecular characterization of class 1 integrons from Irish thermophilic Campylobacter spp. J Antimicrob Chemother 2004; 53:952-7; PMID:15128721; http:// dx.doi.org/10.1093/jac/dkh193
33. Pinto-Alphandary H, Mabilat C, Courvalin P. Emergence of aminoglycoside resistance genes aadA and aadE in the genus Campylobacter. Antimicrob Agents Chemother 1990; 34:1294-6; PMID:2168151; http://dx.doi.org/10.1128/AAC.34.6.1294
34. Sagara H, Mochizuki A, Okamura N, Nakaya R. Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates. Antimicrob Agents Chemother 1987; 31:713-9; PMID:3038005; http:// dx.doi.org/10.1128/AAC.31.5.713
35. Velázquez JB, Jiménez A, Chomón B, Villa TG. Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 1995; 35:173-8; PMID:7768766; http://dx.doi.org/10.1093/ jac/35.1.173
36. Lin J, Michel LO, Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemother 2002; 46:2124-31; PMID:12069964; http://dx.doi.org/10.1128/ AAC.46.7.2124-2131.2002
37. Pumbwe L, Piddock LJ. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol Lett 2002; 206:185-9; PMID:11814661; http://dx.doi. org/10.1111/j.1574-6968.2002.tb11007.x
38. Lin J, Sahin O, Michel LO, Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 2003; 71:4250-9; PMID:12874300; http:// dx.doi.org/10.1128/IAI.71.8.4250-4259.2003
39. Akiba M, Lin J, Barton YW, Zhang Q. Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob Chemother 2006; 57:52-60; PMID:16303882; http://dx.doi. org/10.1093/jac/dki419
40. Jeon B, Wang Y, Hao H, Barton YW, Zhang Q. Contribution of CmeG to antibiotic and oxidative stress resistance in Campylobacter jejuni. J Antimicrob Chemother 2011; 66:79-85; PMID:21081547; http:// dx.doi.org/10.1093/jac/dkq418
41. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000; 403:665-8; PMID:10688204; http://dx.doi. org/10.1038/35001088
42. Corcoran D, Quinn T, Cotter L, Fanning S. An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter. Int J Antimicrob Agents 2006; 27:40-5; PMID:16318913; http://dx.doi.org/10.1016/j.ijantimicag. 2005.08.019
43. Kurincic M, Botteldoorn N, Herman L, Smole Mozina S. Mechanisms of erythromycin resistance of Campylobacter spp. isolated from food, animals and humans. Int J Food Microbiol 2007; 120:186-90; PMID:17889390; http://dx.doi.org/10.1016/j.ijfoodmicro. 2007.03.012
44. Pumbwe L, Randall LP, Woodward MJ, Piddock LJ. Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni. J Antimicrob Chemother 2004; 54:341-7; PMID:15201231; http://dx.doi. org/10.1093/jac/dkh331
45. Page WJ, Huyer G, Huyer M, Worobec EA. Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility. Antimicrob Agents Chemother 1989; 33:297-303; PMID:2543277; http://dx.doi. org/10.1128/AAC.33.3.297
46. Jeon B, Muraoka W, Scupham A, Zhang Q. Roles of lipooligosaccharide and capsular polysaccharide in antimicrobial resistance and natural transformation of Campylobacter jejuni. J Antimicrob Chemother 2009; 63:462-8; PMID:19147521; http://dx.doi. org/10.1093/jac/dkn529
47. Karmali MA, De Grandis S, Fleming PC. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother 1981; 19:593-7; PMID:7247381; http://dx.doi.org/10.1128/ AAC.19.4.593
48. Keo T, Collins J, Kunwar P, Blaser MJ, Iovine NM. Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials. Virulence 2011; 2:30-40; PMID:21266840; http:// dx.doi.org/10.4161/viru.2.1.14752
49. Taylor DE, Ng LK, Lior H. Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors. Antimicrob Agents Chemother 1985; 28:708-10; PMID:3004325; http:// dx.doi.org/10.1128/AAC.28.5.708
50. van Mourik A, Steeghs L, van Laar J, Meiring HD, Hamstra HJ, van Putten JP, et al. Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance. J Biol Chem 2010; 285:15828-36; PMID:20351099; http://dx.doi.org/10.1074/jbc.M110.102061
51. Akhtar SQ. Antimicrobial sensitivity and plasmidmediated tetracycline resistance in Campylobacter jejuni isolated in Bangladesh. Chemotherapy 1988; 34:326-31; PMID:3208549; http://dx.doi. org/10.1159/000238587
52. Boonmar S, Sangsuk L, Suthivarakom K, Padungtod P, Morita Y. Serotypes and antimicrobial resistance of Campylobacter jejuni isolated from humans and animals in Thailand. Southeast Asian J Trop Med Public Health 2005; 36:130-4; PMID:15906655.
53. Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis 1998; 26:341-5; PMID:9502453; http://dx.doi.org/10.1086/516303
54. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS). Human Isolates Final Report, 2010. U.S. Department of Health and Human Services, CDC, 2012. (Accessed at http://www.cdc. gov/narms/reports.htm.)
55. DANMAP. 2011. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. In: The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme; 2012.
56. Van Looveren M, Daube G, De Zutter L, Dumont JM, Lammens C, Wijdooghe M, et al. Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. J Antimicrob Chemother 2001; 48:235-40; PMID:11481294; http://dx.doi. org/10.1093/jac/48.2.235
57. Davidson D. In the matter of enrofloxacin for poultry: Withdrawal of approval of Bayer Corporation's new animal drug application 1 (NADA) 140-828 (Baytril). In: FDA Docket No 00N-1571 2004; 2004.
58. Miflin JK, Templeton JM, Blackall PJ. Antibiotic resistance in Campylobacter jejuni and Campylobacter coli isolated from poultry in the South-East Queensland region. J Antimicrob Chemother 2007; 59:775-8; PMID:17392353; http://dx.doi.org/10.1093/jac/ dkm024
59. Unicomb LE, Ferguson J, Stafford RJ, Ashbolt R, Kirk MD, Becker NG, et al.; Australian Campylobacter Subtyping Study Group. Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia. Clin Infect Dis 2006; 42:1368-74; PMID:16619147; http://dx.doi.org/10.1086/503426
60. Norström M, Hofshagen M, Stavnes T, Schau J, Lassen J, Kruse H. Antimicrobial resistance in Campylobacter jejuni from humans and broilers in Norway. Epidemiol Infect 2006; 134:127-30; PMID:16409659; http:// dx.doi.org/10.1017/S0950268805004814
61. Jain D, Sinha S, Prasad KN, Pandey CM. Campylobacter species and drug resistance in a north Indian rural community. Trans R Soc Trop Med Hyg 2005; 99:207-14; PMID:15653123; http://dx.doi. org/10.1016/j.trstmh.2004.09.006
62. Bester LA, Essack SY. Observational study of the prevalence and antibiotic resistance of Campylobacter spp. from different poultry production systems in KwaZulu-Natal, South Africa. J Food Prot 2012; 75:154-9; PMID:22221370; http://dx.doi.org/10.4315/0362-028X.JFP-11-237
63. Chokboonmongkol C, Patchanee P, Gölz G, Zessin KH, Alter T. Prevalence, quantitative load, and antimicrobial resistance of Campylobacter spp. from broiler ceca and broiler skin samples in Thailand. Poult Sci 2013; 92:462-7; PMID:23300314; http://dx.doi. org/10.3382/ps.2012-02599
64. Haruna M, Sasaki Y, Murakami M, Ikeda A, Kusukawa M, Tsujiyama Y, et al. Prevalence and antimicrobial susceptibility of Campylobacter in broiler flocks in Japan. Zoonoses Public Health 2012; 59:241-5; PMID:22103704; http://dx.doi.org/10.1111/j.1863-2378.2011.01441.x
65. Wardak S, Szych J, Zasada AA, Gierczynski R. Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland. Antimicrob Agents Chemother 2007; 51:1123-5; PMID:17210776; http://dx.doi.org/10.1128/AAC.01187-06
66. Sáenz Y, Zarazaga M, Lantero M, Gastanares MJ, Baquero F, Torres C. Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother 2000; 44:267-71; PMID:10639348; http://dx.doi.org/10.1128/AAC.44.2.267-271.2000
67. Griggs DJ, Johnson MM, Frost JA, Humphrey T, Jørgensen F, Piddock LJ. Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment. Antimicrob Agents Chemother 2005; 49:699-707; PMID:15673754; http://dx.doi. org/10.1128/AAC.49.2.699-707.2005
68. Price LB, Johnson E, Vailes R, Silbergeld E. Fluoroquinolone-resistant Campylobacter isolates from conventional and antibiotic-free chicken products. Environ Health Perspect 2005; 113:557-60; PMID:15866763; http://dx.doi.org/10.1289/ ehp.7647
69. Price LB, Lackey LG, Vailes R, Silbergeld E. The persistence of fluoroquinolone-resistant Campylobacter in poultry production. Environ Health Perspect 2007; 115:1035-9; PMID:17637919; http://dx.doi. org/10.1289/ehp.10050
70. Zhang Q, Lin J, Pereira S. Fluoroquinolone-resistant Campylobacter in animal reservoirs: dynamics of development, resistance mechanisms and ecological fitness. Anim Health Res Rev 2003; 4:63-71; PMID:15134291; http://dx.doi.org/10.1079/AHR200356
71. Luo N, Pereira S, Sahin O, Lin J, Huang S, Michel L, et al. Enhanced in vivo fitness of fluoroquinoloneresistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc Natl Acad Sci U S A 2005; 102:541-6; PMID:15634738; http://dx.doi. org/10.1073/pnas.0408966102
72. Ge B, McDermott PF, White DG, Meng J. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2005; 49:3347-54; PMID:16048946; http://dx.doi. org/10.1128/AAC.49.8.3347-3354.2005
73. Luo N, Sahin O, Lin J, Michel LO, Zhang Q. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob Agents Chemother 2003; 47:390-4; PMID:12499221; http://dx.doi.org/10.1128/ AAC.47.1.390-394.2003
74. Yan M, Sahin O, Lin J, Zhang Q. Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure. J Antimicrob Chemother 2006; 58:1154-9; PMID:17023497; http://dx.doi.org/10.1093/jac/ dkl412
75. Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 1997; 61:377-92; PMID:9293187.
76. Shea ME, Hiasa H. Interactions between DNA helicases and frozen topoisomerase IV-quinolone-DNA ternary complexes. J Biol Chem 1999; 274:22747-54; PMID:10428858; http://dx.doi.org/10.1074/ jbc.274.32.22747
77. Willmott CJ, Critchlow SE, Eperon IC, Maxwell A. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase. J Mol Biol 1994; 242:351-63; PMID:7932695; http://dx.doi.org/10.1006/jmbi.1994.1586
78. Bachoual R, Ouabdesselam S, Mory F, Lascols C, Soussy CJ, Tankovic J. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Microb Drug Resist 2001; 7:257-61; PMID:11759087; http:// dx.doi.org/10.1089/10766290152652800
79. Cooper R, Segal H, Lastovica AJ, Elisha BG. Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains. J Appl Microbiol 2002; 93:241-9; PMID:12147072; http://dx.doi.org/10.1046/j.1365-2672.2002.01650.x
80. Payot S, Cloeckaert A, Chaslus-Dancla E. Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microb Drug Resist 2002; 8:335-43; PMID:12523631; http:// dx.doi.org/10.1089/10766290260469606
81. Gootz TD, Martin BA. Characterization of highlevel quinolone resistance in Campylobacter jejuni. Antimicrob Agents Chemother 1991; 35:840-5; PMID:1649570; http://dx.doi.org/10.1128/ AAC.35.5.840
82. Jesse TW, Englen MD, Pittenger-Alley LG, Fedorka-Cray PJ. Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle. J Appl Microbiol 2006; 100:682-8; PMID:16553723; http://dx.doi.org/10.1111/j.1365-2672.2005.02796.x
83. Farnell MB, Donoghue AM, Cole K, Reyes-Herrera I, Blore PJ, Donoghue DJ. Campylobacter susceptibility to ciprofloxacin and corresponding fluoroquinolone concentrations within the gastrointestinal tracts of chickens. J Appl Microbiol 2005; 99:1043-50; PMID:16238734; http://dx.doi.org/10.1111/j.1365-2672.2005.02712.x
84. McDermott PF, Bodeis SM, English LL, White DG, Walker RD, Zhao S, et al. Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones. J Infect Dis 2002; 185:837-40; PMID:11920303; http://dx.doi.org/10.1086/339195
85. Takahashi T, Ishihara K, Kojima A, Asai T, Harada K, Tamura Y. Emergence of fluoroquinolone resistance in Campylobacter jejuni in chickens exposed to enrofloxacin treatment at the inherent dosage licensed in Japan. J Vet Med B Infect Dis Vet Public Health 2005; 52:460-4; PMID:16364022; http://dx.doi. org/10.1111/j.1439-0450.2005.00890.x
86. Ellis-Pegler RB, Hyman LK, Ingram RJ, McCarthy M. A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community. J Antimicrob Chemother 1995; 36:259-63; PMID:8537277; http://dx.doi.org/10.1093/ jac/36.1.259
87. Segreti J, Gootz TD, Goodman LJ, Parkhurst GW, Quinn JP, Martin BA, et al. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis 1992; 165:667-70; PMID:1313069; http:// dx.doi.org/10.1093/infdis/165.4.667
88. Wretlind B, Strömberg A, Ostlund L, Sjögren E, Kaijser B. Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin. Scand J Infect Dis 1992; 24:685-6; PMID:1465591; http://dx.doi.org/10.3109/00365549209054659
89. Ruiz J, Goñi P, Marco F, Gallardo F, Mirelis B, Jimenez De Anta T, et al. Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol 1998; 42:223-6; PMID:9580533.
90. Wang Y, Huang WM, Taylor DE. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob Agents Chemother 1993; 37:457-63; PMID:8384814; http://dx.doi.org/10.1128/ AAC.37.3.457
91. Piddock LJ, Ricci V, Pumbwe L, Everett MJ, Griggs DJ. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J Antimicrob Chemother 2003; 51:19-26; PMID:12493783; http://dx.doi. org/10.1093/jac/dkg033
92. Engberg J, Neimann J, Nielsen EM, Aerestrup FM, Fussing V. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg Infect Dis 2004; 10:1056-63; PMID:15207057; http://dx.doi.org/10.3201/eid1006.030669
93. Feodoroff FB, Lauhio AR, Sarna SJ, Hänninen ML, Rautelin HI. Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates. Clin Microbiol Infect 2009; 15:188-92; PMID:19154485; http://dx.doi.org/10.1111/j.1469-0691.2008.02657.x
94. Helms M, Simonsen J, Olsen KE, Mølbak K. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registrybased cohort study. J Infect Dis 2005; 191:1050-5; PMID:15747238; http://dx.doi.org/10.1086/428453
95. Nelson JM, Smith KE, Vugia DJ, Rabatsky-Ehr T, Segler SD, Kassenborg HD, et al. Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection. J Infect Dis 2004; 190:1150-7; PMID:15319866; http://dx.doi.org/10.1086/423282
96. Sonnevend A, Kovács J, Pál T, Akawi N, Nagelkerke N, Schneider G. Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance. Scand J Infect Dis 2011; 43:905-11; PMID:21905953; http:// dx.doi.org/10.3109/00365548.2011.603743
97. Wassenaar TM, Kist M, de Jong A. Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections. Int J Antimicrob Agents 2007; 30:195-201; PMID:17420115; http:// dx.doi.org/10.1016/j.ijantimicag.2007.01.019
98. Asai T, Harada K, Ishihara K, Kojima A, Sameshima T, Tamura Y, et al. Association of antimicrobial resistance in Campylobacter isolated from food-producing animals with antimicrobial use on farms. Jpn J Infect Dis 2007; 60:290-4; PMID:17881869.
99. Animal Drugs @ FDA. Center for Veterinary Medicine, 2012. (Accessed at http://www.accessdata.fda.gov/ scripts/animaldrugsatfda/index.cfm.)
100. Cagliero C, Mouline C, Cloeckaert A, Payot S. Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2006; 50:3893-6; PMID:16940070; http://dx.doi.org/10.1128/ AAC.00616-06
101. Lin J, Yan M, Sahin O, Pereira S, Chang YJ, Zhang Q. Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrob Agents Chemother 2007; 51:1678-86; PMID:17353243; http://dx.doi.org/10.1128/ AAC.01411-06
102. Payot S, Bolla JM, Corcoran D, Fanning S, Mégraud F, Zhang Q. Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes Infect 2006; 8:1967-71; PMID:16713726; http:// dx.doi.org/10.1016/j.micinf.2005.12.032
103. Egger R, Korczak BM, Niederer L, Overesch G, Kuhnert P. Genotypes and antibiotic resistance of Campylobacter coli in fattening pigs. Vet Microbiol 2012; 155:272-8; PMID:21899961; http://dx.doi. org/10.1016/j.vetmic.2011.08.012
104. Gibreel A, Taylor DE. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 2006; 58:243-55; PMID:16735431; http://dx.doi.org/10.1093/jac/ dkl210
105. Lachance N, Gaudreau C, Lamothe F, Larivière LA. Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Antimicrob Agents Chemother 1991; 35:813-8; PMID:1854162; http:// dx.doi.org/10.1128/AAC.35.5.813
106. Lehtopolku M, Kotilainen P, Haanperä-Heikkinen M, Nakari UM, Hänninen ML, Huovinen P, et al. Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2011; 55:5939-41; PMID:21911571; http://dx.doi.org/10.1128/ AAC.00314-11
107. Mamelli L, Prouzet-Mauléon V, Pagès JM, Mégraud F, Bolla JM. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J Antimicrob Chemother 2005; 56:491-7; PMID:16055509; http://dx.doi.org/10.1093/jac/ dki253
108. Pérez-Boto D, López-Portolés JA, Simón C, Valdezate S, Echeita MA. Study of the molecular mechanisms involved in high-level macrolide resistance of Spanish Campylobacter jejuni and Campylobacter coli strains. J Antimicrob Chemother 2010; 65:2083-8; PMID:20647243; http://dx.doi.org/10.1093/jac/ dkq268
109. Ren GW, Wang Y, Shen Z, Chen X, Shen J, Wu C. Rapid detection of point mutations in domain V of the 23S rRNA gene in erythromycin-resistant Campylobacter isolates by pyrosequencing. Foodborne Pathog Dis 2011; 8:375-9; PMID:21166562; http:// dx.doi.org/10.1089/fpd.2010.0676
110. Vacher S, Menard A, Bernard E, Santos A, Megraud F. Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCR. Microb Drug Resist 2005; 11:40-7; PMID:15770093; http://dx.doi.org/10.1089/ mdr.2005.11.40
111. Fouts DE, Mongodin EF, Mandrell RE, Miller WG, Rasko DA, Ravel J, et al. Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species. PLoS Biol 2005; 3:e15; PMID:15660156; http://dx.doi. org/10.1371/journal.pbio.0030015
112. Gibreel A, Wetsch NM, Taylor DE. Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrob Agents Chemother 2007; 51:3212-6; PMID:17606685; http://dx.doi.org/10.1128/AAC.01592-06
113. Payot S, Avrain L, Magras C, Praud K, Cloeckaert A, Chaslus-Dancla E. Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli. Int J Antimicrob Agents 2004; 23:468-72; PMID:15120725; http:// dx.doi.org/10.1016/j.ijantimicag.2003.12.008
114. Logue CM, Danzeisen GT, Sherwood JS, Thorsness JL, Mercier BM, Axtman JE. Repeated therapeutic dosing selects macrolide-resistant Campylobacter spp. in a turkey facility. J Appl Microbiol 2010; 109:1379-88; PMID:20497488; http://dx.doi.org/10.1111/j.1365-2672.2010.04765.x
115. Almofti YA, Dai M, Sun Y, Haihong H, Yuan Z. Impact of erythromycin resistance on the virulence properties and fitness of Campylobacter jejuni. Microb Pathog 2011; 50:336-42; PMID:21377522; http:// dx.doi.org/10.1016/j.micpath.2011.02.009
116. Han F, Pu S, Wang F, Meng J, Ge B. Fitness cost of macrolide resistance in Campylobacter jejuni. Int J Antimicrob Agents 2009; 34:462-6; PMID:19651494; http://dx.doi.org/10.1016/j.ijantimicag.2009.06.019
117. Hao H, Dai M, Wang Y, Peng D, Liu Z, Yuan Z. 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni. Microb Drug Resist 2009; 15:239-44; PMID:19857128; http://dx.doi.org/10.1089/ mdr.2009.0008
118. Zeitouni S, Collin O, Andraud M, Ermel G, Kempf I. Fitness of macrolide resistant Campylobacter coli and Campylobacter jejuni. Microb Drug Resist 2012; 18:101-8; PMID:22324770; http://dx.doi. org/10.1089/mdr.2011.0188
119. EFSA. The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2010. Eur Food Safety Auth J 2012; 10:2598-830.
120. Smith SI, Sansa TI, Coker AO. Antibiotic susceptibility patterns and beta-lactamase production of animal and human isolates of Campylobacter in Lagos, Nigeria. Z Naturforsch C 1999; 54:583-6; PMID:10488568.
121. Gibreel A, Kos VN, Keelan M, Trieber CA, Levesque S, Michaud S, et al. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob Agents Chemother 2005; 49:2753-9; PMID:15980346; http://dx.doi.org/10.1128/ AAC.49.7.2753-2759.2005
122. Caldwell DB, Wang Y, Lin J. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrob Agents Chemother 2008; 52:3947-54; PMID:18779354; http://dx.doi. org/10.1128/AAC.00450-08
123. Jeon B, Zhang Q. Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter. J Antimicrob Chemother 2009; 63:946-8; PMID:19279049; http://dx.doi.org/10.1093/jac/ dkp067
124. Huyer MP, Hancock T, Page RW. Outer membrane porin protein of Campylobacter jejuni. FEMS Microbiol Lett 1986; 37:247-50; http://dx.doi. org/10.1111/j.1574-6968.1986.tb01803.x
125. Hancock RE, Bell A. Antibiotic uptake into gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1988; 7:713-20; PMID:2850910; http://dx.doi.org/10.1007/ BF01975036
126. Vaara M. Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. Antimicrob Agents Chemother 1993; 37:354-6; PMID:8383945; http:// dx.doi.org/10.1128/AAC.37.2.354
127. Logan SM, Trust TJ. Structural and antigenic heterogeneity of lipopolysaccharides of Campylobacter jejuni and Campylobacter coli. Infect Immun 1984; 45:210-6; PMID:6203838.
128. Naess V, Hofstad T. Isolation and chemical composition of lipopolysaccharide from Campylobacter jejuni. Acta Pathol Microbiol Immunol Scand B 1982; 90:135-9; PMID:7080831.
129. Giesbrecht P, Kersten T, Maidhof H, Wecke J. Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol Mol Biol Rev 1998; 62:1371-414; PMID:9841676.
130. Alfredson DA, Korolik V. Isolation and expression of a novel molecular class D beta-lactamase, OXA-61, from Campylobacter jejuni. Antimicrob Agents Chemother 2005; 49:2515-8; PMID:15917560; http://dx.doi. org/10.1128/AAC.49.6.2515-2518.2005
131. Griggs DJ, Peake L, Johnson MM, Ghori S, Mott A, Piddock LJ. Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni. Antimicrob Agents Chemother 2009; 53:3357-64; PMID:19506058; http://dx.doi. org/10.1128/AAC.01655-08
132. Lachance N, Gaudreau C, Lamothe F, Turgeon F. Susceptibilities of beta-lactamase-positive and-negative strains of Campylobacter coli to beta-lactam agents. Antimicrob Agents Chemother 1993; 37:1174-6; PMID:8390812; http://dx.doi.org/10.1128/ AAC.37.5.1174
133. Tajada P, Gomez-Graces JL, Alós JI, Balas D, Cogollos R. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors. Antimicrob Agents Chemother 1996; 40:1924-5; PMID:8843305.
134. Wright EP, Knowles MA. Beta-lactamase production by Campylobacter jejuni. J Clin Pathol 1980; 33:904-5; PMID:6968758; http://dx.doi.org/10.1136/ jcp.33.9.904-b
135. Alfredson DA, Korolik V. Identification of putative zinc hydrolase genes of the metallo-beta-lactamase superfamily from Campylobacter jejuni. FEMS Immunol Med Microbiol 2007; 49:159-64; PMID:17266723; http://dx.doi.org/10.1111/j.1574-695X.2006.00197.x
136. Potter ME, Blaser MJ, Sikes RK, Kaufmann AF, Wells JG. Human Campylobacter infection associated with certified raw milk. Am J Epidemiol 1983; 117:475-83; PMID:6837559.
137. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. [second page, table of contents.]. Microbiol Mol Biol Rev 2001; 65:232-60; PMID:11381101; http://dx.doi.org/10.1128/ MMBR.65.2.232-260.2001
138. Bolla JM, Loret E, Zalewski M, Pagés JM. Conformational analysis of the Campylobacter jejuni porin. J Bacteriol 1995; 177:4266-71; PMID:7543469.
139. Kervella M, Fauchère JL, Fourel D, Pagès JM. Immunological cross-reactivity between outer membrane pore proteins of Campylobacter jejuni and Escherichia coli. FEMS Microbiol Lett 1992; 78:281-5; PMID:1337053; http://dx.doi. org/10.1111/j.1574-6968.1992.tb05582.x
140. Epe B, Woolley P, Hornig H. Competition between tetracycline and tRNA at both P and A sites of the ribosome of Escherichia coli. FEBS Lett 1987; 213:443-7; PMID:3104093; http://dx.doi.org/10.1016/0014-5793(87)81539-9
141. Goldman RA, Hasan T, Hall CC, Strycharz WA, Cooperman BS. Photoincorporation of tetracycline into Escherichia coli ribosomes. Identification of the major proteins photolabeled by native tetracycline and tetracycline photoproducts and implications for the inhibitory action of tetracycline on protein synthesis. Biochemistry 1983; 22:359-68; PMID:6337627; http://dx.doi.org/10.1021/bi00271a020
142. Manavathu EK, Hiratsuka K, Taylor DE. Nucleotide sequence analysis and expression of a tetracyclineresistance gene from Campylobacter jejuni. Gene 1988; 62:17-26; PMID:2836268; http://dx.doi. org/10.1016/0378-1119(88)90576-8
143. Salyers AA, Speer BS, Shoemaker NB. New perspectives in tetracycline resistance. Mol Microbiol 1990; 4:151-6; PMID:2181236; http://dx.doi. org/10.1111/j.1365-2958.1990.tb02025.x
144. Dasti JI, Gross U, Pohl S, Lugert R, Weig M, Schmidt-Ott R. Role of the plasmid-encoded tet(O) gene in tetracycline-resistant clinical isolates of Campylobacter jejuni and Campylobacter coli. J Med Microbiol 2007; 56:833-7; PMID:17510271; http://dx.doi. org/10.1099/jmm.0.47103-0
145. Taylor DE. Plasmid-mediated tetracycline resistance in Campylobacter jejuni: expression in Escherichia coli and identification of homology with streptococcal class M determinant. J Bacteriol 1986; 165:1037-9; PMID:3005233.
146. Batchelor RA, Pearson BM, Friis LM, Guerry P, Wells JM. Nucleotide sequences and comparison of two large conjugative plasmids from different Campylobacter species. Microbiology 2004; 150:3507-17; PMID:15470128; http://dx.doi.org/10.1099/ mic.0.27112-0
147. Taylor DE, Courvalin P. Mechanisms of antibiotic resistance in Campylobacter species. Antimicrob Agents Chemother 1988; 32:1107-12; PMID:3056250; http://dx.doi.org/10.1128/AAC.32.8.1107
148. Sahin O, Plummer PJ, Jordan DM, Sulaj K, Pereira S, Robbe-Austerman S, et al. Emergence of a tetracyclineresistant Campylobacter jejuni clone associated with outbreaks of ovine abortion in the United States. J Clin Microbiol 2008; 46:1663-71; PMID:18322054; http://dx.doi.org/10.1128/JCM.00031-08
149. Bérdy J. CRC handbook of antibiotic compounds. Boca Raton, Fla.: CRC Press; 1980.
150. Jana S, Deb JK. Molecular understanding of aminoglycoside action and resistance. Appl Microbiol Biotechnol 2006; 70:140-50; PMID:16391922; http:// dx.doi.org/10.1007/s00253-005-0279-0
151. Taber HW, Mueller JP, Miller PF, Arrow AS. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev 1987; 51:439-57; PMID:3325794.
152. Bryan LE, Kwan S. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob Agents Chemother 1983; 23:835-45; PMID:6351731; http://dx.doi.org/10.1128/AAC.23.6.835
153. Bryan LE, Van Den Elzen HM. Gentamicin accumulation by sensitive strains of Escherichia coli and Pseudomonas aeruginosa. J Antibiot (Tokyo) 1975; 28:696-703; PMID:810469; http://dx.doi. org/10.7164/antibiotics.28.696
154. Hermann T. Aminoglycoside antibiotics: old drugs and new therapeutic approaches. Cell Mol Life Sci 2007; 64:1841-52; PMID:17447006; http://dx.doi. org/10.1007/s00018-007-7034-x
155. Ouellette M, Gerbaud G, Lambert T, Courvalin P. Acquisition by a Campylobacter-like strain of aphA-1, a kanamycin resistance determinant from members of the family Enterobacteriaceae. Antimicrob Agents Chemother 1987; 31:1021-6; PMID:2821885; http:// dx.doi.org/10.1128/AAC.31.7.1021
156. Tenover FC, Fennell CL, Lee L, LeBlanc DJ. Characterization of two plasmids from Campylobacter jejuni isolates that carry the aphA-7 kanamycin resistance determinant. Antimicrob Agents Chemother 1992; 36:712-6; PMID:1503433; http://dx.doi. org/10.1128/AAC.36.4.712
157. Tenover FC, Filpula D, Phillips KL, Plorde JJ. Cloning and sequencing of a gene encoding an aminoglycoside 6'-N-acetyltransferase from an R factor of Citrobacter diversus. J Bacteriol 1988; 170:471-3; PMID:2826403.
158. Tenover FC, Gilbert T, O'Hara P. Nucleotide sequence of a novel kanamycin resistance gene, aphA-7, from Campylobacter jejuni and comparison to other kanamycin phosphotransferase genes. Plasmid 1989; 22:52-8; PMID:2550983; http://dx.doi.org/10.1016/0147-619X(89)90035-8
159. Olkkola S, Juntunen P, Heiska H, Hyytiäinen H, Hänninen ML. Mutations in the rpsL gene are involved in streptomycin resistance in Campylobacter coli. Microb Drug Resist 2010; 16:105-10; PMID:20370506; http://dx.doi.org/10.1089/ mdr.2009.0128
160. Hannula M, Hänninen ML. Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli. J Med Microbiol 2008; 57:851-5; PMID:18566143; http://dx.doi.org/10.1099/ jmm.0.47823-0
161. Pumbwe L, Piddock LJV. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol Lett 2002; 206:185-9; PMID:11814661; http://dx.doi. org/10.1111/j.1574-6968.2002.tb11007.x